Total hospital cost | Out-of-pocket patient payments | ||||||
---|---|---|---|---|---|---|---|
Variables | No. (%) | per episode, 2012 US$ | per episode, 2012 US$ | ||||
Mean (±95% CI) | p value | Median | Mean (±95% CI) | p value | Median | ||
All subjects | 367 (100%) | 4,193 (±414) | 2,837 | 2,230 (±254) | 1,405 | ||
Age in years | |||||||
18-40 | 41 (11.2%) | 5,160 (±1,791) | 0.182 @ | 3,456 | 3,031 (±730) | 0.001 @ | 2,468 |
41-60 | 202 (55.0%) | 4,089 (±544) | 2,723 | 2,105 (±303) | 1,337 | ||
61-80 | 124 (33.8%) | 4,044 (±624) | 3,022 | 2,167 (±514) | 1,369 | ||
Gender | |||||||
Male | 139 (37.9%) | 5,286 (±864) | < 0.001 # | 3,432 | 2,795 (±558) | 0.006 # | 1,510 |
Female | 228 (62.1%) | 3,527 (±389) | 2,651 | 1,885 (±218) | 1,334 | ||
Cancer type | |||||||
Breast CA | 135 (36.8%) | 2,898 (±369) | < 0.001 @ | 2,208 | 1,567 (±249) | < 0.001 @ | 1,167 |
Lymphoma | 79 (21.5%) | 6,560 (±1,362) | 4,159 | 3,389 (±827) | 1,972 | ||
Gastrointestinal CA | 39 (10.6%) | 4,145 (±859) | 3,432 | 1,927 (±541) | 1,349 | ||
Head and Neck CA | 34 (9.3%) | 4,565 (±1,665) | 3,150 | 2,502 (±867) | 1,486 | ||
Lung CA | 31 (8.4%) | 3,353 (±912) | 2,314 | 1,861 (±947) | 1,097 | ||
Sarcoma | 16 (4.4%) | 3,857 (±1,119) | 3,479 | 2,331 (±701) | 2,194 | ||
Genitourinary CA | 15 (4.1%) | 4,898 (±2,803) | 2,654 | 2,629 (±1,498) | 1,340 | ||
Gynecologic CA | 13 (3.5%) | 4,615 (±1,482) | 3,858 | 2,877 (±1,317) | 2,251 | ||
Other/Unknown CA | 5 (1.4%) | 2,707 (±1,199) | 2,359 | 1,403 (±677) | 1,364 | ||
Therapeutic GCSF | |||||||
No | 48 (13.1%) | 3,752 (±1,088) | 0.064 # | 2,392 | 1,544 (±384) | 0.007 # | 1,181 |
Yes | 319 (86.9%) | 4,267 (±450) | 2,950 | 2,338 (±286) | 1,487 | ||
Admission source | |||||||
ED | 195 (53.1%) | 3,721 (±503) | < 0.001 @ | 2,577 | 1,979 (±259) | 0.001 @ | 1,302 |
NCCS clinic | 121 (33.0%) | 3,671 (±594) | 2,451 | 2,069 (±409) | 1,377 | ||
Inpatient referral | 51 (13.9%) | 7,238 (±1,601) | 4,436 | 3,570 (±1,163) | 2,112 | ||
Severe sepsis | |||||||
No | 315 (85.8%) | 3,590 (±350) | < 0.001 # | 2,571 | 2,044 (±264) | < 0.001 # | 1,283 |
Yes | 52 (14.2%) | 7,879 (±1,744) | 6,105 | 3,358 (±772) | 2,073 | ||
MASCC risk | |||||||
Low | 300 (81.7%) | 3,790 (±412) | < 0.001 # | 2,571 | 2,162 (±283) | 0.034 # | 1,316 |
High | 67 (18.3%) | 5,998 (±1,249) | 4,436 | 2,533 (±574) | 1,711 | ||
Ward class | |||||||
Class A1 | 30 (8.2%) | 5,879 (±1,875) | 0.039 @ | 4,086 | 5,245 (±1,889) | < 0.001 @ | 3,828 |
Class B1 | 48 (13.1%) | 3,699 (±784) | 2,479 | 3,749 (±835) | 2,512 | ||
Class B2 | 194 (52.9%) | 3,855 (±540) | 2,727 | 1,696 (±205) | 1,256 | ||
Class C | 95 (25.8%) | 4,602 (±923) | 3,185 | 1,600 (±313) | 1,100 |